If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 69,829 shares of Common Stock held of record by MIF II (as defined in Item 2(a) of the Original Schedule 13D), (ii) 106,194 shares of Common Stock issuable upon exercise of the Private Warrants (as defined in the Original Schedule 13D), (iii) 1,466,090 shares of Common Stock issuable upon conversion of the January 2024 Term Loans (as defined in Item 3 below) as of February 14, 2025, (iv) 10,701 shares of Common Stock issuable upon conversion of the September 2023 Term Loans (as defined in Item 3 below) as of February 14, 2025, and (v) 5,211,706 shares of Common Stock underlying the Series A Preferred Stock (as defined in Item 3 below). Excludes 13,873 Earn-Out Shares (as defined in the Original Schedule 13D) to be released upon the occurrence of a Triggering Event (as defined in the Original Schedule 13D). MIP II (as defined in Item 3 of the Original Schedule 13D) is the sole general partner of MIF II and may be deemed to have voting, investment and dispositive power with respect to these securities. Adam Sharkawy, a member of the Issuer's board of directors, and Carmichael Roberts are the managing members of MIP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Percentage based on 30,185,791 shares of Common Stock outstanding as of February 3, 2025, as reported on the Issuer's Form S-3 filed with the SEC (as defined in the Original 13D) on February 3, 2025 (the S-3), plus (i) 106,194 shares of Common Stock issuable upon exercise of the Private Warrants, (ii) 1,466,090 shares of Common Stock issuable upon conversion of the January 2024 Term Loans as of February 14, 2025, (iii) 10,701 shares issuable upon the conversion of the September 2023 Term Loans as of February 14, 2025 and (iv) 5,211,706 shares of Common Stock underlying the Series A Preferred Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 69,829 shares of Common Stock held of record by MIF II, (ii) 106,194 shares of Common Stock issuable upon exercise of the Private Warrants, (iii) 1,466,090 shares of Common Stock issuable upon conversion of the January 2024 Term Loans as of February 14, 2025, (iv) 10,701 shares of Common Stock issuable upon conversion of the September 2023 Term Loans as of February 14, 2025, and (v) 5,211,706 shares of Common Stock underlying the Series A Preferred Stock. Excludes 13,873 Earn-Out Shares to be released upon the occurrence of a Triggering Event. MIP II is the sole general partner of MIF II and may be deemed to have voting, investment and dispositive power with respect to these securities. Adam Sharkawy, a member of the Issuer's board of directors, and Carmichael Roberts are the managing members of MIP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Percentage based on 30,185,791 shares of Common Stock outstanding as of February 3, 2025, as reported on the S-3, plus (i) 106,194 shares of Common Stock issuable upon exercise of the Private Warrants, (ii) 1,466,090 shares of Common Stock issuable upon conversion of the January 2024 Term Loans as of February 14, 2025, (iii) 10,701 shares issuable upon the conversion of the September 2023 Term Loans as of February 14, 2025 and (iv) 5,211,706 shares of Common Stock underlying the Series A Preferred Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
Shares of Common Stock reported in Items 7 and 9 are held by Adam Sharkawy individually. Shares reported in Items 8 and 10 consist of (i) 69,829 shares of Common Stock held of record by MIF II, (ii) 106,194 shares of Common Stock issuable upon exercise of the Private Warrants, (iii) 1,466,090 shares of Common Stock issuable upon conversion of the January 2024 Term Loans as of February 14, 2025, (iv) 10,701 shares of Common Stock issuable upon conversion of the September 2023 Term Loans as of February 14, 2025, and (v) 5,211,706 shares of Common Stock underlying the Series A Preferred Stock. Excludes 13,873 Earn-Out Shares to be released upon the occurrence of a Triggering Event. MIP II is the sole general partner of MIF II and may be deemed to have voting, investment and dispositive power with respect to these securities. Adam Sharkawy, a member of the Issuer's board of directors, and Carmichael Roberts are the managing members of MIP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Percentage based on 30,185,791 shares of Common Stock outstanding as of February 3, 2025, as reported on the S-3, plus (i) 106,194 shares of Common Stock issuable upon exercise of the Private Warrants, (ii) 1,466,090 shares of Common Stock issuable upon conversion of the January 2024 Term Loans as of February 14, 2025, (iii) 10,701 shares issuable upon the conversion of the September 2023 Term Loans as of February 14, 2025 and (iv) 5,211,706 shares of Common Stock underlying the Series A Preferred Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
Consists of (i) 69,829 shares of Common Stock held of record by MIF II, (ii) 106,194 shares of Common Stock issuable upon exercise of the Private Warrants, (iii) 1,466,090 shares of Common Stock issuable upon conversion of the January 2024 Term Loans as of February 14, 2025, (iv) 10,701 shares of Common Stock issuable upon conversion of the September 2023 Term Loans as of February 14, 2025, and (v) 5,211,706 shares of Common Stock underlying the Series A Preferred Stock. Excludes 13,873 Earn-Out Shares to be released upon the occurrence of a Triggering Event. MIP II is the sole general partner of MIF II and may be deemed to have voting, investment and dispositive power with respect to these securities. Adam Sharkawy, a member of the Issuer's board of directors, and Carmichael Roberts are the managing members of MIP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Percentage based on 30,185,791 shares of Common Stock outstanding as of February 3, 2025, as reported on the S-3, plus (i) 106,194 shares of Common Stock issuable upon exercise of the Private Warrants, (ii) 1,466,090 shares of Common Stock issuable upon conversion of the January 2024 Term Loans as of February 14, 2025, (iii) 10,701 shares issuable upon the conversion of the September 2023 Term Loans as of February 14, 2025 and (iv) 5,211,706 shares of Common Stock underlying the Series A Preferred Stock.


SCHEDULE 13D


 
Material Impact Partners II, LLC
 
Signature:/s/Carmichael Roberts
Name/Title:Carmichael Roberts, Managing Member
Date:02/25/2025
 
Material Impact Fund II, L.P.
 
Signature:/s/Carmichael Roberts
Name/Title:Carmichael Roberts, Managing Member of Material Impact Partners II, LLC, its General Partner
Date:02/25/2025
 
Adam Sharkawy
 
Signature:/s/Adam Sharkawy
Name/Title:Adam Sharkawy
Date:02/25/2025
 
Carmichael Roberts
 
Signature:/s/Carmichael Roberts
Name/Title:Carmichael Roberts
Date:02/25/2025